Slide 1: Fourth quarter
Medical Solutions Engineered Solutions Fourth quarter CEO Christer Wahlquist CFO Per-Ola Holmström 5 February, 2026
Slide 2: Q4 summary – Nolato Group
Q4 summary – Nolato Group A global solutions provider established on three continents ● Sales totaled SEK 2,272 million (2,382) SEKm - Organic growth of 2% adjusted for currency 12000 - Increased growth rate for Medical Solutions of 5% while 11000 Engineered Solutions decreased by 1%, adjusted for 1
Slide 3: Full year 2025 summary – Nolato Group
Full year 2025 summary – Nolato Group ● Sales totaled SEK 9,462 million (9,664) A global solutions provider established on three continents - Increase of 2% adjusted for currency ● Operating profit (EBITA) increased to SEK 1,065 SEKm million (958) 12000 11000 ● EBITA margin of 11.3% (9.9) 10000 - Ma
Slide 4: One Group – two business areas
One Group – two business areas Nolato Medical Solutions Engineered Solutions Our offering as a strategic partner for selected Development and manufacture of complex Design, development, industrialization and global customers comprises development and product systems and components for medical manufa
Slide 5: Medical Solutions – sustainable growth and global expansion
Medical Solutions – sustainable growth and global expansion SEKm 5500 5000 4500 4000 3500 3000 1,314 153 2500 SALES EBITA 2000 SEKm, Q4 SEKm, Q4 1500 58 11.6 1000 500 SHARE OF THE GROUP EBITA MARGIN %, Q4 %, Q4 0 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 5 5
Slide 6: Medical Solutions – focused product areas
Medical Solutions – focused product areas Pharma Diagnostics Medical Devices Drug Delivery In-vitro-diagnostics (IVD) Endoscopy & General Surgery Cardiology Continence care Pharma Packaging Other 6
Slide 7: Medical Solutions – Q4
Medical Solutions – Q4 ● Sales totaled SEK 1,314 million (1,359) - An increase of 5% adjusted for currency - The Drug Delivery market area continued to exhibit growth (autoinjectors and pen injectors) Q4 Full year - In vitro diagnostic performed positively compared with the beginning of 2025 SEKm 20
Slide 8: Engineered Solutions – advanced technology and high-productivity manufacturing
Engineered Solutions – advanced technology and high-productivity manufacturing SEKm 8000 7500 7000 6500 6000 5500 5000 4500 4000 964 95 3500 3000 SALES EBITA 2500 SEKm, Q4 SEKm, Q4 2000 1500 42 9.9 1000 500 SHARE OF THE GROUP EBITA MARGIN 0 %, Q4 %, Q4 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21
Slide 9: Engineered Solutions – focused product areas
Engineered Solutions – focused product areas Materials Consumer Electronics Automotive Other Hygiene 9
Slide 10: Engineered Solutions – Q4
Engineered Solutions – Q4 ● Sales totaled SEK 964 million (1,033) - Adjusted for currency, a decrease of 1% Q4 Full year - Strong growth for Materials, which increased by 10%, adjusted for currency SEKm 2025 2024 2025 2024 - Sustained positive performance for Consumer Electronics, particularly Asia
Slide 11: Group financial highlights
Group financial highlights Full year Full year SEKm Q4 2025 Q4 2024 2025 2024 Net sales 2,272 2,382 9,462 9,664 Operating profit (EBITA) 236 240 1,065 958 EBITA margin (%) 10.4 10.1 11.3 9.9 Profit after financial income and expense 210 215 983 848 Profit after tax 151 163 777 658 Effective tax (%)
Slide 12: Sustainability - Development
Sustainability - Development Near-Term targets & Net-Zero ● Scope 1 & 2 emissions reduced with 96% in absolute terms from base year 2021, vs target 70% for 2030 (see graph) ● Scope 3 upstream emissions reduced with 30% in absolute terms from base year 2021, vs target 25% ● Well ahead of Near-term ta
Slide 13: Current situation
Current situation Medical Solutions Engineered Solutions • Continued growth strategy – high market activity • Advanced market positions • Innovation and sustainability • Established position in new product areas • Broad customer base with longstanding, close • Focus on innovative and sustainable sol
Slide 14: Thank you.
Thank you. This presentation may contain forward-looking statements. When used in this presentation, words such as “anticipate”, “believe”, “estimate”, “expect”, “plan” and “project” are intended to identify forward-looking statements. Such statements could encompass risks and uncertainties pertaini